Society for Investigative Dermatology skin disease co-morbidities project launch conference proceedings.
Society for Investigative Dermatology skin disease co-morbidities project launch conference proceedings.
复制标题
DOI：
10.1038/jid.2008.417
复制
发表时间：
2009-03
期刊：
影响因子：
--
通讯作者：
Heather Yarnall Schultz
中科院分区：
文献类型：
--
作者：
Heather Yarnall Schultz
2008年10月，来自学术界、政府和工业界的约90名皮肤病学研究人员参加了皮肤病共病负担项目启动会议。该会议由皮肤病研究学会（SID）主办，由高级科学和医学顾问洛厄尔金匠、项目和研究高级主任贝基·米尼洛和首席执行官丹尼斯·巴托斯组织。本次会议的总体目标是启动一个多年的多学科项目，促进多个临床和基础科学学科之间的互动和合作，包括皮肤病学，心脏病学，肿瘤学，精神病学，流行病学和工业。通过研究报告、对现有数据资源的审查和小组讨论，与会者能够确定潜在的富有成效的跨学科合作和资金来源。SID计划与政府、工业界、学术界以及非营利性和营利性卫生部门合作开展这项工作。在这项倡议中，共患病指的是皮肤病与一种或多种疾病同时发生，患病率高于偶然性。在这方面，皮肤病可能是原因，相关的风险因素，或预测合并症。皮肤病和第二种疾病的同时存在使得这些疾病的研究变得复杂，并强调了合作的必要性。
Approximately 90 dermatologic researchers from academia, government, and industry convened in October 2008 for the Burden of Skin Disease Co-Morbidities Project Launch Conference.* The conference, sponsored by the Society for Investigative Dermatology (SID), was organized by Lowell Goldsmith, Senior Scientific and Medical Advisor; Becky Minnillo, Senior Director, Programs and Research; and Dennis Barbour, Chief Executive Officer. The overarching goal of this conference, which launches a multi-year, multidisciplinary project, was to facilitate interaction and collaboration across multiple clinical and basic science disciplines, including dermatology, cardiology, oncology, psychiatry, epidemiology, and industry. Through research presentations, examination of the existing data resources, and group panel discussions, the participants were able to identify potentially productive interdisciplinary collaborations and funding sources. SID plans to partner in this effort with government, industry, academia, and the nonprofit and for-profit health sectors.For the purposes of this initiative, comorbidity refers to the presence of skin disease concurrent with one or more conditions that occur with prevalence higher than chance. In this respect, dermatological disease may be the cause, an associated risk factor, or a predictor of comorbidity. The simultaneous presence of skin disease and a second condition makes the study of these conditions complex and emphasizes the need for collabora-